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Nojima and colleagues demonstrate
widespread co-transcriptional splicing of
mammalian genes by complex formation
between the active spliceosome and the
RNA polymerase II S5P CTD isoform.
RNA processing intermediates within this
complex are invariably detected with the
transcript cleaved at 50 ss but already
spliced to upstream exons, implying a
sequential splicing process..
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The highly intronic nature of protein coding genes in
mammals necessitates a co-transcriptional splicing
mechanism as revealed by mNET-seq analysis.
Immunoprecipitation of MNase-digested chromatin
with antibodies against RNA polymerase II (Pol II)
shows that active spliceosomes (both snRNA and
proteins) are complexed to Pol II S5P CTD during
elongation and co-transcriptional splicing. Notably,
elongatingPol II-spliceosomecomplexes formstrong
interactions with nascent transcripts, resulting in
footprints of approximately 60 nucleotides. Also,
splicing intermediates formed by cleavage at the
50 splice site are associated with nearly all spliced
exons. These spliceosome-bound intermediates are
frequently ligated to upstream exons, implying a
sequential, constitutive, and U12-dependent splicing
process. Finally, lack of detectable spliced products
connected to the Pol II active site in human HeLa or
murine lymphoid cells suggests that splicing does
not occur immediately following 30 splice site synthe-
sis. Our results imply that most mammalian splicing
requires exon definition for completion.
INTRODUCTION
Eukaryotic protein coding genes often contain multiple introns
that are removed from primary transcripts of RNA polymerase
II (Pol II) by splicing. This is catalyzed by the spliceosome,
comprising five snRNAs and more than 200 proteins, a subset
of which form functional ribonucleoprotein particles. Exon-intron
boundaries are defined by short consensus sequences at the
50 and 30 splice sites (ss) that mediate recognition by the spliceo-
some. Spliceosome assembly also requires recognition of an
intronic catalytic adenosine (branch point) and, for mammalian
introns, a polypyrimidine tract located between the branch pointMolecular Cell 72, 369–379, Oc
This is an open access article undadenosine and 30 ss. Within the 3D structure of the spliceosome,
these key pre-mRNA sequences are forced into an RNA catalytic
center that triggers splicing (Papasaikas and Valcárcel, 2016).
This involves two transesterification reactions. First, the 20 hy-
droxyl group (OH) of the branch point adenosine carries out a
nucleophilic attack on the phosphate group at the 50 ss; then
the exposed 30 OH of the upstream exon cleaves the lariat struc-
tured intron away from the 30 ss, resulting in covalent joining of
the two exons (Patel and Steitz, 2003).
Exactly how two splice sites separated by extensive intronic
sequence (in mammals, 1 to 100 kb) are brought together during
early stages of spliceosome assembly remains a puzzle.
Possibly, the 50 exon is tethered to elongating Pol II until com-
plete synthesis of the downstream intron has occurred. This
would maintain the two splice sites in close proximity, irrespec-
tive of intron size (Hollander et al., 2016). Co-transcriptional teth-
ering of the 50 exon may involve the flexible C-terminal domain
(CTD) of Pol II’s largest subunit, Rbp1, which acts to coordinate
transcription with pre-mRNA processing (Heidemann et al.,
2013; Zaborowska et al., 2016). Mammalian CTD comprises
52 repeats of a heptad with the consensus amino acid sequence
YSPTSPS. This is extensively modified post-translationally,
principally by phosphorylation to S2P, S5P, S7P, T4P, and Y1P
(Hintermair et al., 2012; Hsin and Manley, 2012; Mayer et al.,
2012). At the promoter, Pol II CTD is largely unphosphorylated,
but then, following initial elongation, it is converted to S5P and
Y1P. This may facilitate recruitment of the capping enzyme com-
plex. Further elongation correlates with a reduction in S5P but an
increase in S2P. Transcription past the polyadenylation site then
triggers recruitment of the 30 end cleavage and polyadenylation
machinery to S2P. It is possible that T4P also plays a role here,
as it has recently been correlated with Pol II termination regions
(Hintermair et al., 2012; Schlackow et al., 2017).
The kinetics of co-transcriptional splicing in budding yeast has
been extensively characterized (Wallace and Beggs, 2017). The
short size of yeast (S. cerevisiae) introns implies an intron defini-
tion model for the splicing mechanism (Ast, 2004; Barrass and
Beggs, 2003; Chen and Manley, 2009). In particular, Pol II
pausing has been observed over the 30 ss of downstream exons
in the few genes that harbor introns. This may facilitate rapidtober 18, 2018 ª 2018 The Authors. Published by Elsevier Inc. 369
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spliceosome recruitment and intron splicing (Alexander et al.,
2010). Furthermore, splicing in S. cerevisiae has been shown to
occur within a short kinetic window following Pol II elongation
through an intron and into the adjoining exon (Oesterreich
et al., 2016). In mammals, the prevalence and larger size of
introns instead predicts an exon definition mechanism. Binding
of regulatory proteins to specific RNA sequences (splicing
enhancers and inhibitors) act to select exons for splicing by pro-
moting communication between 30 ss and 50 ss flanking the exon
(Ast, 2004; Chen andManley, 2009). The interplay between these
regulatory factors dictates both constitutive and alternative
splicing. Notably, transcription kinetics strongly impact splicing
decisions. Slow Pol II elongation rates favor splicing by allowing
more time for spliceosome assembly (Dujardin et al., 2014;
Muñoz et al., 2010). Exons in general display a higher nucleo-
some density, suggesting that chromatin structure acts as a
kinetic barrier to Pol II elongation (Nieto Moreno et al., 2015;
Schwartz and Ast, 2010).
We have developed a strategy for native elongation transcript
sequencing using mammalian cells (mNET-seq). We found an
accumulation of transcripts mapping precisely to the 30 end of
exons, as expected for intermediates formed after the first trans-
esterification splicing reaction (Nojima et al., 2015). This indi-
cates that splicing must occur within a stable complex formed
between the spliceosome and Pol II. Unexpectedly, splicing in-
termediates were preferentially detected by antibodies specific
for S5P CTD, suggesting that splicing occurs in association
with this Pol II phospho-isoform. We now show biochemically
and bymass spectroscopy that both protein and snRNA compo-
nents of the spliceosome associate with Pol II complexes con-
taining S5P CTD. Notably, initial cleavage of the intron creates
a dominant 50 ss intermediate that remains embedded in the
Pol II-associated spliceosome. In contrast, 30 ss intermediates
corresponding to released intron lariats were detected at very
low levels, suggesting fast dissociation of the spliceosome
from Pol II upon completion of splicing.
RESULTS
Catalytically Active Spliceosome Associates with S5P
CTD Pol II
mNET-seq involves immunoprecipitation (IP) of human Pol II
elongation complexes from chromatin solubilized by micro-
coccal nuclease (MNase) digestion with Pol II antibodies specific
for different CTD isoforms (Nojima et al., 2015; Schlackow et al.,
2017). RNA is isolated from these complexes and sequenced byFigure 1. Spliceosome Proteins Associate with S5P CTD Pol II
(A) Diagram outliningmNET-seq and associatedmass spectroscopy strategies. P
phosphorylation (P) indicated in red edging. Nucleosomes shown in gray and splic
asterisks indicate free 30 OH at the end of the nascent transcript and cleaved 50
(B) Volcano plots comparing S2P, S5P, and T4P CTD Pol II IPs to mock IPs. Speci
for identification of all enriched proteins).
(C) Scatterplots of fold enrichment for Pol II subunits (highlighted in blue), SUPT6
(D) Western blots with indicated antibodies of micrococcal nuclease-solubilized H
no specific antibody (mIgG) or antibodies to total S2P and S5P CTD Pol II.
(E) Diagram outlining the glycerol gradient fractionation of micrococcal nuclease
(F) Western blots across glycerol gradient fractions.
(G) Western blots on pooled light, middle, and heavy fractions from glycerol gradlinker ligation onto the RNA 30 ends derived either from nascent
RNA in the Pol II active site or co-transcriptional RNA processing
intermediates. Notably, we showed that co-transcriptional
splicing is associated with Pol II phosphorylated on the CTD
serine 5 position (S5P) (Nojima et al., 2015; Schlackow et al.,
2017). We reasoned that, as well as sequencing IPed RNA, we
should also be able to establish the protein composition of these
specifically IPed Pol II complexes by mass spectroscopy (MS),
termed the mNET-MS method (Figure 1A). A label-free quantita-
tive proteomics approach (Hubner et al., 2010; Hubner and
Mann, 2011) was used to determine the abundance of proteins
enriched in Pol II complexes IPed with antibodies specific for
S5P, S2P, and T4P CTD relative to a mock (nonspecific IgG) IP
control. The fold increase of spectral intensities was compared
to p values determined by t tests, as previously described
(Harlen et al., 2016), generating volcano plots (Figure 1B). Signif-
icant interactors were taken to be proteins identified as enriched
using a false discovery rate of 0.05. We show that complexes
precipitated by all three antibodies contained Pol II subunits,
transcription factors, histones, chromatin-associated proteins,
RNA-binding proteins, and RNA-processing factors (Table S1).
Scatterplots with fold-enrichment reveal that Pol II subunits
were precipitated with similar efficiency to SUPT6H and
PHRF1 (Figure 1C). Remarkably, complexes precipitated by
the S5P CTD antibody contained multiple SR and SR-related
proteins (SRSF7, 9,10; SCAF1, 11), as well as spliceosome com-
ponents. These include Sm proteins, U1 and U2 snRNP-specific
proteins, and components of spliceosomal A, B, Bact, and C
complexes (Figures 1B and S1; Table S1). This was confirmed
by western blot analysis of fractions IPed with S5P compared
to S2P antibodies; S5P-specific enrichment was observed for
the U5 snRNP protein, SNRP116, the splicing scaffold protein,
PRPF8, and the U2 snRNP protein SF3B3 (Figure 1D). There
are several possible reasons for this selectivity. Either spliceoso-
mal components interact specifically with S5P CTD or, possibly,
S5P and S2P epitopes display differential antibody accessibility.
However, we consider this later possibility unlikely, as a recent
proteomic analysis in yeast also revealed an enrichment of
spliceosomal components in S5P Pol II complexes (Harlen
et al., 2016).
As an alternative approach to studying the interaction between
Pol II and the spliceosome, chromatin was solubilized by MNase
treatment and then fractionated on a 10%–30% glycerol
gradient followed by protein extraction from 22 separated frac-
tions (Figure 1E). These were subjected to western blotting
with antibodies against total, S2P, and S5P Pol II as well as U5ol II denoted in dark blue with CTD tail and heptad repeat sequencemodified by
eosome in orange. Grey arrows denotemicrococcal nuclease cleavage and red
ss splicing intermediate.
fically, enriched proteins are highlighted in black and color coded (see Table S1
H, and PHRF1 in S5P versus S2P IPs and S5P versus T4P IPs.
eLa cell chromatin before (input) and after immunoprecipitation (IP) with either
-solubilized chromatin.
ient.
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snRNP protein SNRP116 and histone H3 (Figure 1F). Significant
amounts of S2P, S5P Pol II, and histone H3 were detected in
the middle and heavy fractions. However, the heavy fraction
contained most of the snRNP116 (Figure 1F). Further analysis
with a wider range of antibodies against pooled light, middle,
and heavy fractions confirms that U5 snRNP proteins were pre-
dominantly associated with the heavy fraction (Figure 1G). In
contrast, U2 snRNP proteins appeared similarly distributed in
the middle and heavy fractions, and U1 snRNP proteins were
predominantly associated with the middle fraction (Figure 1G).
The histone mark H3K9me2, which is typically associated with
transcriptional repression, was predominantly in the middle frac-
tion, whereas the histone elongation mark H3K36me3 was in
both the middle and heavy fractions. These results indicate
that the heavy fraction contains spliceosome-associated S5P
Pol II-elongating polymerases on a chromatin template.
Since S5P CTD modified Pol II interacts with protein compo-
nents of the spliceosome,we also analyzed spliceosomal snRNA.
We reasoned thatmNET-seq should detect the free 30 OHends of
mature spliceosomal snRNA associated with Pol II. Indeed, an
accumulation of mNET-seq signal was found mapping to the 30
ends of U1, U2, U4, and U5 snRNAs (Figure 2A). As expected,
no 30 end peak was detected in U6 snRNA, which contains a
20,30 cyclicphosphate terminal groupat the30 end (LundandDahl-
berg, 1992). Lower mNET-seq peaks were also found at the 30
ends of the minor spliceosome U11, U12, and U4atac snRNAs,
but not in U6atac snRNA (Figure 2B). A weak 30 end signal was
further detected for U7 snRNA, which is associated with histone
pre-mRNA 30 end processing. As expected, no 30 end peak was
detected for U3 snRNA, which is involved in the processing of
Pol I-synthesized pre-rRNA (Figures 2C and S2A). To confirm
the specificity of these results, we tested whether the spliceo-
some snRNAs’ 30 end signal was sensitive to treatment with
the strong detergent empigen. We have previously employed
empigen to separate RNA processing complexes from Pol II
(Schlackowet al., 2017). NotablymNET-seq signals of bothmajor
andminor spliceosome snRNAs 30 endswere substantially dimin-
ished (Figure 2D). A more detailed comparison of the association
of mature spliceosomal snRNA (based on mNET-seq 30 end
reads) for all phosphoCTD isoformsofPol II revealedhigher signal
with S5P CTD antibody for U2, U5, and the minor spliceosome
snRNA. In contrast, U1 snRNA showed similar read levels for all
five phospho CTD isoforms (Figure 2E).
To complete this mNET-seq analysis of spliceosome-associ-
atedRNA,wealso tested the distributionof the50 ss splicing inter-
mediate.Wefirst confirmed thatRNA fragmentsmapping to the50
ss are predominantly detected by S5PCTD antibody as opposed
to S2P, Y1P, T4P and S7P antibodies (Figure S2B). We also
comparedmNET-seqprofileswithdifferentCTDS5P-specifican-
tibodies; MABI0603 (MBL international), routinely used in our
mNET-seq/S5P analysis, and ab5131 (Abcam), often used in
Pol II ChIP analysis. Similar profiles of 50 ss peaks were obtained
(FiguresS2CandS2D), consistentwithourpreviousChIPanalysis
that showed their same specificity for S5P CTD (Nojima et al.,
2015). We next generated mNET-seq/S5P and S2P libraries
from the heavy and middle fractions of the glycerol gradient of
MNase-digested chromatin. Notably, the 50 ss splicing intermedi-
ate was only detected from the heavy S5P library as shown for372 Molecular Cell 72, 369–379, October 18, 2018TARS (Figure S2E) and in a metagene profile of 40,896 aligned
exon intron junctions corresponding to spliced events (Fig-
ure S2F). These results confirm the existence of a complex be-
tween Pol II and the spliceosome in heavy fractions. Finally, since
the 50 ss splicing intermediate detected by mNETseq/S5P is em-
pigen sensitive (FigureS2G),wepredict that the50 ssRNA is asso-
ciated with the spliceosome rather than with the Pol II active site.
In summary, these data strongly argue that phosphorylation of
CTD serine 5 residues is not restricted to transcription initiation
but is also present during elongation and co-transcriptional
splicing. It is clear from the range of data presented (Figures 1,
2, S1, and S2) that catalytically active spliceosome stably asso-
ciates with S5P CTD Pol II.
mNET-Seq Reveals Elongating RNA Pol II Footprints
Wenext employedmNET-seq to investigate the extent of nascent
transcript interaction with both Pol II and the spliceosome. Since
this procedure involvesMNase digestion before RNA purification
and library preparation, it can be used for Pol II and spliceosome
footprinting analysis akin to ribosome footprinting. Previously, we
size selected RNA of 30–100 nt for library preparation (Nojima
et al., 2015; Schlackow et al., 2017). To explore a larger RNA
size range, we prepared new mNETseq/S5P libraries using
long-sized (60–160 nt) or short-sized (20–60 nt) RNA fractions
with a read length of 150 bp and 75 bp, respectively (Figure 3A).
To analyze Pol II footprints independently of spliceosome assem-
bly,weexamined the length of readsmapping to a region from the
TSS to +150 nucleotides in first exons that were at least 200 nt
long.Most reads (> 85%)obtained from the short-sizedRNA frac-
tions were 18–40 nt long with a peak at 27 nt, whereas those for
the long-sized RNA fractions were 40–100 nt long with a peak at
60 nt (Figure 3B). We infer that Pol II complexes protect a total
of either 27 or 60 nascent transcript nucleotides. Previous struc-
tural data indicate that nascent RNA must be at least 15 nt in
length to reach the Pol II surface (Andrecka et al., 2009; Ketten-
berger et al., 2004) and 17–23 nt to reach the active site of the
capping enzyme,which binds Pol II at the endof theRNAexit tun-
nel (Martinez-Rucobo et al., 2015). To determinewhether binding
of the capping enzyme to Pol II explains the 20–30 nt footprint, we
compared the length of reads mapping to the same exons on the
region from the TSS to +50 nts and from +100 to +150 nts (Fig-
ure S3A). A similar footprint was obtained irrespective of read po-
sition with mNET-seq libraries prepared after IP with either S5P
andS2Pantibodies (FigureS3A). This suggests that oncenascent
transcripts emerge from the polymerase exit channel, they are
protected from MNase by RNA-binding proteins such as the
capping enzyme. The larger 60-nt footprint obtained from long-
sized RNA fractions (Figure 3B) was further characterized. Anal-
ysis ofmNET-seqprofiles obtained from the long-sizedRNA frac-
tions no longer shows the characteristic peaks corresponding to
promoter proximal transcriptional pausing that typically occurs
within the first 50 bp of the transcription start site (TSS). This is
shown both for the TSS region of DAP3 (Figure 3C) and a meta-
gene profile of long and short mNET-seq/S5P TSS reads (Fig-
ure 3D). We conclude that the mNET-seq protocol distinguishes
two types of elongating Pol II complexes, a smaller one corre-
sponding to a nascent RNA footprint of 27 nt and a larger one pro-








































































































































































































Figure 2. Spliceosome snRNAs Associate with S5P CTD Pol II
(A–C) mNET-seq/S5P profiles over indicated snRNA genes: major spliceosome snRNAs (A); minor spliceosome snRNAs (B); non-spliceosome snRNAs (C).
(D) Aggregated read counts (mean RPM)mapping to indicated snRNA genes in untreated and empigen-treated samples (data from three independentmNET-seq/
S5P libraries). Data are represented as mean ± SEM.
(E) Aggregated read counts (mean RPM) obtained with antibodies to color-coded CTD modifications and mapping to indicated snRNA genes (data from three
independent mNET-seq libraries with each CTD antibody). Data are represented as mean ± SEM.Next, we examined the read length of splicing intermediates
in mNETseq/S5P and S2P libraries prepared from the short
and long-sized RNA fractions (Figure S3B). The results show
that the most frequent length of both 50 ss intermediates
(i.e., exons that have been cleaved at the 50 ss but not yet
ligated) and 30 ss intermediates (i.e., released intron lariats)
is 30–32 nt in the short libraries and 57–60 nt in the longlibraries. As splicing intermediates are spliceosome-bound,
we conclude that these fragments result from the footprinting
of splicing complexes associated with S5P and S2P CTD Pol
II. Notably, a very recent analysis of RNA co-purifying with
late-stage spliceosomes similarly revealed that splicing com-
plexes protect a total of approximately 56 nucleotides (Chen







































































































































Figure 3. mNET-seq reveals elongating RNA Pol II footprints
(A) Size selection of RNA for different mNET-seq/S5P libraries.
(B) Length of reads mapping within the first 150 nts for 3,690 exons with length > 200 nts.
(C) mNET-seq/S5P profiles over the promoter-proximal region of DAP3. Comparison of profiles from libraries prepared with long and short RNA fragments.
(D) Metagene analysis of mNET-seq/S5P profiles over the promoter-proximal region from libraries prepared with long and short RNA fragments.
(E) Diagram depicting footprints of Pol II complexes on short and long nascent RNA fragments in micrococcal nuclease digested chromatin.
(F) Venn diagram comparing splicing events covered by at least three spliced reads in three independent mNET-seq/S5P libraries prepared from long and short
RNA fragments.
(G) Venn diagram comparing splicing events covered by three or more spliced reads in three independent mNET-seq/S5P and S2P libraries prepared from long
RNA fragments.
(H) Aggregated spliced read counts obtained in HeLa and TAP cells with or without Empigen treatment (data from three independent mNET-seq/S5P libraries
prepared from long RNA fragments). Data are represented as mean ± SEM.mNET-Seq Does Not Detect Spliced Nascent
Transcripts
We show above (Figures 1 and 2) that the spliceosome forms a
complex with Pol II. We therefore tested if splicing can occur
immediately after the 30 ss in a nascent transcript emerges at
the Pol II surface. We reasoned that, if this was the case, then
mNET-seq should detect spliced nascent transcripts. Analysis
of mNET-seq libraries prepared from the short RNA fraction
revealed spliced exon reads corresponding to approximately
300 splicing events, while over 20,000 splicing events were
detected in libraries prepared from the long RNA fraction (Fig-374 Molecular Cell 72, 369–379, October 18, 2018ure 3F). Most spliced events detected by spliced exon reads
were predominantly observed in mNET-seq/S5P libraries (Fig-
ure 3G), consistent with our data indicating that complexes
of Pol II and associated catalytically active spliceosomes are
preferentially IPed by S5P CTD antibodies (Figures 1, 2, S1,
and S2). At this stage in our analysis, we added additional
mNET-seq/S5P libraries for the mouse lymphoid cell line TAP
to generalize our results on co-transcriptional splicing to a
different mammal and cell type. We also performed heat-map
analysis of mNET-seq signals and detected more S5P signals
on spliced exons than other phospho CTD isoforms (Figures
S3C–S3E). Notably thesemNET-seq/S5P signals are resistant to
empigen, suggesting that they are derived from nascent tran-
scripts connected to the Pol II active site (Figure S3F). These em-
pigen-resistant mNET-seq/S5P signals do not show any bias
across exons (Figure S3G). This indicates that S5P CTD Pol II
pausing is exon position independent. In contrast, the vast ma-
jority of the spliced reads in human and murine libraries display
empigen sensitivity (Figure 3H), showing that they are nascent
RNAs associated with Pol II (presumably within the spliceosome)
but not from the Pol II active site. The combined analysis of hu-
man and murine libraries led us to appreciate that cDNA primers
used in next-generation sequencing can internally prime on spli-
ceosome-derived spliced transcripts as well as priming on the
linker ligated onto RNA 30 ends (either 50 ss intermediates or
Pol II active site RNA). This was evident from a conserved 4-nt
sequence (TGGA from Illumina TruSeq RT primer) present at
the 30 end of the spliced RNA reads that corresponds to the
30 end of the cDNA primer (Figure S3H). Evenwhen the RT primer
was changed, we still detected the same internal priming issue
(AGAT from NEB smRNA RT primer). Overall, these results
demonstrate that even though numerous spliced read tran-
scripts are specifically detectable in our mNET-seq/S5P li-
braries, they do not reflect immediate splicing of transcripts
synthesized by a polymerase that has elongated just a few nts
past the 30 ss as seen in S. cerevisiae (Oesterreich et al., 2016).
Although spliced reads may correspond to contaminating
fully spliced mRNA that is detected due to mis-priming, it is un-
likely that contaminants would be specifically enriched by S5P
antibody. Rather, these spliced reads likely derive from frag-
ments of spliced products connected to Pol-II-associated
spliceosomes.
We further reasoned that if a spliceosome assembles onto
nascent pre-mRNA as soon as the 30 ss is exposed at the Pol
II surface, akin to the binding of the capping machinery, this
should result in extended nascent transcripts fragments pro-
tected from MNase digestion. We therefore analyzed the length
distribution of reads mapping to included or skipped exons, but
we obtained similar footprint sizes (Figure S3I). Taken together,
the lack of detectable spliced read transcripts connected to
the Pol II active site and the absence of combined Pol II-spliceo-
some footprints argue that most splicing occurs when Pol II has
elongated for a significant distance beyond the 30 ss. These
observations are consistent with the view that most mammalian
splicing requires exon definition for successful completion and
therefore, unlike yeast, mammalian splicing only occurs
following full exon synthesis.
Co-Transcriptional Splicing Is Globally Associated with
50 ss Intermediates
The ability of mNET-seq to map splicing intermediates enables
in-depth investigation of the extent of co-transcriptional splicing
in vivo. Because the first step of the splicing reaction (i.e., cleav-
age at the 50 ss) results in multiple mNET-seq reads mapping to
the very last nucleotide of exons, we sought to identify the pro-
portion of exons with 50 ss peaks. For this we adapted a previ-
ously described algorithm that finds nucleotides where the
read density is at least three standard deviations above the
mean in a defined window (Churchman and Weissman, 2011).Upon analyzing replicates of mNET-seq/S5P long and short
RNA libraries, we found substantial overlap of approximately
25,000 exons showing 50 ss peaks between three independent
datasets (Figure S4A). In contrast, 30 ss peaks that correspond
to released intron lariats were only detected at very low levels
(up to 170 cases) (Figure 4A). Like 50 ss peaks, these few cases
of 30 ss peaks were again predominantly detected by the S5P
antibody (Figure S4B). We also investigated the intensity of the
signal at the end of exons in the long and short mNET-seq/S5P
libraries. As shown for FUS (Figure S4C) and in ameta gene anal-
ysis (Figure S4D), higher 50 ss peaks were seen for the long li-
brary. We next ascertained the proportion of splicing events in
the HeLa cell transcriptome that show a 50 ss intermediate by
performing a global analysis of the percent splicing index (PSI).
This measures the inclusion level of internal exons based on
nucleoplasm-derived RNA-seq (Nojima et al., 2015) and shows
that nearly all exons with 50 ss peaks are fully included in mature
mRNAs (PSI > 0.9). Remarkably, 88%of efficiently spliced exons
show a 50 ss mNET-seq peak, indicating that this splicing inter-
mediate is a dominant splicing feature (Figure 4B).
mNET-Seq Reveals Sequential Co-transcriptional
Splicing
We suggest above that the majority of mammalian splicing oc-
curs in association with Pol II but with a lag between synthesis
of the 30 ss and assembly of the spliceosome onto the nascent
transcript. We next investigated the prevalence of upstream
spliced exons covalently connected to 50 ss splicing intermedi-
ates, as this would be indicative of sequential co-transcriptional
splicing. In HeLa long-read mNET-seq/S5P libraries, we de-
tected over 4,000 exons with spliced reads mapping to splicing
intermediates (Figure 4C). Although these were more frequently
detected in mNET-seq/S5P, both S5P and S2P libraries con-
tained approximately one quarter of all spliced exon reads asso-
ciated with splicing intermediates (Figure S4E). We also detect
50 ss intermediates associated with spliced reads in TAP long-
read mNET-seq/S5P libraries, indicating that both cell types
display a predominance of spliced relative to unspliced reads
associated with the 50 ss intermediate (Figure 4D). Thus, when
these exons are cleaved at the 50 ss, their upstream intron has
already been spliced (Figure 4E). However, sequential splicing
is not an obligatory rule, as we also observe 50 ss intermediates
associated with unspliced reads, particularly in the case of alter-
natively spliced exons (Figure 4F). Remarkably, the rarer exam-
ples of minor U12-type introns also show a predominance for
spliced over unspliced 50 ss intermediates in both HeLa and
TAP cells (Figures 4G and S4F). Although previous studies sug-
gested that U12-associated splicing is less efficient than splicing
of U2-type introns (Turunen et al., 2013), our results demonstrate
that U12-type introns have been excised by the time a spliceo-
some initiates splicing of the downstream exons.
DISCUSSION
We have previously described a dominant splicing intermediate
generated by the first catalytic step in splicing, which is associ-
ated with S5P CTD-modified Pol II (Nojima et al., 2015). This
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Figure 4. mNET-Seq Reveals Sequential Co-transcriptional Splicing
(A) Number of exons with a peak of mNET-seq/S5P signal detected at either the 50 ss or the 30 ss (only peaks detected in all three libraries prepared with long and
short RNA fragments were considered).
(B) Percent spliced in (PSI) score for all exons containing a peak of mNET-seq/S5P signal at 50 ss (aggregated data from three libraries). Pie chart depicts the
proportion of spliced exons (exons with PSI > 90% estimated from nucleoplasmic RNA-seq data) that contain a peak of mNET-seq/S5P signal at the 50 ss
(aggregated data from three libraries).
(C) Venn diagram comparing spliced 50 ss intermediates detected in three independent mNETseq/S5P and mNET-seq/S2P libraries prepared with long RNA
fragments.
(D) Ratio between spliced and unspliced reads for all splicing events associated with at least one spliced read mapping to the 50 ss intermediate. Graphs depict
frequency of events with indicated proportions of spliced reads in HeLa and TAP cells.
(E–G) Diagrams showing spliced and unspliced 50 ss intermediates associated with a constitutive exon (E), an alternative exon (F) and a U12-type intron (G).
(H) Model showing sequential co-transcriptional splicing associated with S5P CTD of Pol II.elongating Pol II complex within a coIPed spliceosome. Our new
results now establish this hypothesis (Figure 4H). Thus, both spli-
ceosome-associated proteins (Figure 1) and snRNAs (Figure 2)
selectively associate with S5P CTD Pol II. In particular the
observed enrichment for U5 snRNP aswell asmost protein com-
ponents of spliceosomal Bact and C complexes (Figures 1, 2,
and S1) shows that the catalytically active spliceosome
associates with S5PCTDPol II during co-transcriptional splicing.
Interestingly, we detect lower levels of U1 snRNP in our datasets.
Even though U1 snRNP is a known Pol II interactor (Das et al.,376 Molecular Cell 72, 369–379, October 18, 20182007; Harlen et al., 2016), its association is likely transient in na-
ture, possibly because it acts as a splice site selector factor
rather than playing a direct role in spliceosome-mediated catal-
ysis (Papasaikas and Valcárcel, 2016). Furthermore, it also acts
to block the recognition of cryptic polyA signals often found
within large mammalian introns (Oh et al., 2017). We consistently
observed that spliceosomal proteins and snRNAs were
much more abundant in Pol II complexes IPed with antibodies
specific for S5P CTD than antibodies specific for S2P and T4P
CTD. In the case of T4P, ChIP-seq analysis suggests that this
modification is associated with transcription termination (Hinter-
mair et al., 2012). Its lack of spliceosomal association is therefore
predictable. In contrast, numerous ChIP-seq studies revealed
that Pol II complexes containing S5P-modified CTD are enriched
at the promoter proximal region and diminish thereafter (for a
comprehensive review, see Eick and Geyer, 2013). However, a
splicing-related accumulation of S5P Pol II along gene bodies
was found both in HeLa cells (Batsché et al., 2006) and in yeast
(Alexander et al., 2010; Chathoth et al., 2014). Moreover, a recent
proteomic analysis of phospho-specific Pol II complexes in yeast
revealed that the interactome of S5P-modified Pol II is enriched
for spliceosomal components (Harlen et al., 2016). Our results
extend these observations by showing that a S5P Pol II-associ-
ated, catalytically active spliceosome exists as a stable entity in
human cells (Figure 4H). We suggest that S5P CTD is not
restricted to transcription initiation but is also present during
elongation and co-transcriptional splicing.
It is currently unclear which CTD kinases and phosphatases
are associated with CTD phosphorylation during co-transcrip-
tional splicing. CDK7, CDK9, and CDK12 are all known to act
as CTD kinases (Bartkowiak et al., 2010; Hsin and Manley,
2012). However, these enzymes were not detected in our
mNET-MS experiments. Possibly interactions between kinase
and Pol II will be transient. Notably, we did detect RPAP2 phos-
phatase-interacting proteins RPRD1A and RPRD1B in S5P Pol II
complexes (Table S1). RPRD1A and RPRD1B have been re-
ported to act as CTD scaffolds to coordinate S5 dephosphoryla-
tion by RPAP2 (Ni et al., 2014).
Togetherwith spliceosome components associatedwith Pol II
complexes, our mNET-seq analysis also uncovers new informa-
tion about splicing intermediates that form co-transcriptionally.
We find that the vastmajority of splicing events (90%) are asso-
ciated with a 50 ss peak corresponding to the splicing intermedi-
ate formed after initial 50 ss cleavage generated by the formation
of the intron lariat (Figure 4C). Cleaved short exons (< 60 nt) can
be entirely protected from MNase digestion by the spliceosome
complex, allowing interrogation of whether splicing to the previ-
ously synthesized exon has occurred. Overall, we found splicing
intermediates containing short exons frequently spliced to the
upstream exon. As shown in Figure S4G for OSTF1, each of
the 4 adjacent 50 ss intermediates is associated with upstream
exon spliced reads. In effect, this means that mNET-seq detects
previously transcribed nascent pre-mRNA with its introns
already excised but that is still in the process of active synthesis
of its downstream regions. Remarkably, we observe intermedi-
ates containing the rare U12-type introns already excised (Fig-
ures 4G and S4F). Thus, although minor introns have been
reported to be slowly spliced (Niemel€a and Frilander, 2014),
mNET-seq reveals that U12 introns are efficiently co-transcrip-
tionally spliced. In contrast, a higher proportion of unspliced
intermediates is detected in the case of alternative upstream
splicing events (Figure 4F), consistent with the view that not all
exon pairs in a pre-mRNA are ligated with similar kinetics (Pan-
dya-Jones and Black, 2009; Rabani et al., 2014; Wetterberg
et al., 1996) and that alternative splicing tends to be less efficient
than constitutive splicing (Khodor et al., 2011, 2012).
It is notable that our observed pattern of mammalian co-tran-
scriptional splicing differs from that proposed for S. cerevisiae. Inyeast, splicing has been shown to occur when Pol II is still tran-
scribing the downstream exon, implying an intron definition
mechanism (Oesterreich et al., 2016). Instead, in mammalian
genes, which tend to have short exons separated by very long in-
trons, the exon definition model posits that splicing occurs after
Pol II has transcribed beyond the entire exon (Keren et al., 2010).
In our analysis, we show that most mammalian splicing occurs
after Pol II has elongated beyond the downstream 50 ss. Even
so, we predict that splicing is a normally rapid process that
occurs as soon as the elongating Pol II completes transcription
of a particular exon.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
HeLa cells and TAP cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) and RPMI, respectively, with 10% fetal
bovine serum (FBS). Empigen treatment and in vivo splicing inhibition with Pla-B were as previously described (Nojima et al., 2015;
Schlackow et al., 2017).
METHOD DETAILS
Short and long RNAs mNET-seq
Four 15 cm plates of HeLa cells (3.2x107 cells) were used for mNET-seq of fractionated RNAs. Immunoprecipitated samples with
Pol II antibodies (MABI0602 and MABI0603) from solubilized chromatin of HeLa cells were washed eight times with 1 mL of
NET-2 buffer (50 mM Tris-HCl pH7.4, 150 mM NaCl and 0.05% NP-40). 50 phosphate is added to IPed RNAs using T4 PNK for
6 min as described before (Nojima et al., 2016). The 50 p-RNAs were purified according to a protocol of TRI reagent (Sigma-Aldrich).
The purified RNAs were run on denaturing gel (6% Novex TBE-Urea gel, Thermo-Fisher Scientific) with 1xTBE buffer (Thermo-Fisher
Scientific) at 300mA for 10min. The two RNA fractions (20-60nt and 60-160nt) were size-selected on the gel. The RNAs were put into
a 0.5mL tube with three small holes that were made by 26G needle and the 0.5mL tube was put onto a 1.5mL tube. The gels were
slushed by centrifuge at 16,000 g for 1 min. The slushed RNAs were incubated with 400 mL RNA elution buffer (1M NaOAc and 1mM
EDTA) at 25C for 1 hour. The solution with gel was put into Spin X column (Coaster #8160) with 2 glass filters (Whatman #1823-010)
and the column was centrifuged at 16,000 g for 1 min. The flow through (400 mL) was purified with ethanol precipitation. Finally, RNA
libraries were prepared using Illumina TruSeq small RNA library prep kit (Illumina) or NEBNext small RNA library prep kit for Illumina
(NEB) with minimum cycles of PCR (1215 cycles). The expected sizes of PCR products from short and long RNAs are 150-180bp
and 180-280bp, respectively. The libraries were sequenced using Hiseq4000 (Illumina) at Wellcome Trust Centre of HumanGenetics,
Oxford.
Mass spectrometry with filter-aid sample preparation
Four 15 cm plates of HeLa cells (3.2x107 cells) were used for mass spectrometry experiment. Immunoprecipitated samples with Pol II
antibodies from solubilized chromatin of HeLa cells were washed eight times with 1 mL of NET-2 buffer (50 mM Tris-HCl pH7.4,
150mMNaCl and 0.05%NP-40) and then once with 500 mL of NET buffer (50mMTris-HCl pH7.4 and 150mMNaCl). After NET buffer
was removed completely, washed beads were incubated in 300 mL of lysis buffer (8 M Urea and 100 mM Triethylammonium bicar-
bonate buffer (TEAB) pH 8.0) for 30 min at room temperature. The mixture with beads was transferred to a Vivacon 10 kDa MWCO
centrifugal concentrator (viva) and centrifuged at 16,000 g for 15min at room temperature. The filter on tube was washed with 200 mL
of lysis buffer twice by centrifugation at 16,000 g for 15 min at room temperature. The samples were incubated in 200 mL of reduction
buffer (8 M Urea, 100 mM TEAB pH 8.0 and 20 mM Tris (2-carboxyethyl)phosphine hydrochloride solution pH 7.0) on the filter for
30min, followed by centrifugation at 16,000 g for 15min at room temperature. Next, 30min incubation with 200 mL of alkylation buffer
(8 M Urea, 100 mM TEAB pH 8.0 and 20 mM chloroiodoacetamide) was performed in the dark place. The reaction solution was
removed by centrifugation at 16,000 g for 15 min at room temperature. The samples were washed with wash buffer (1 M Urea,
50mMTEAB pH 8.0) twice and then digested with 1 mg trypsin in 100 mL wash buffer for 30min at 37C on the filter. The trypsinization
was repeated oncemore for over-night at 37C. The samples were collected by 16,000 g for 15min at room temperature as the follow
through and desalted with a C18 column. Finally, the purified peptides were analyzed by electrospray tandemmass spectrometry at
the central proteomics facility in University of Oxford.
Glycerol gradient experiment
6 mL of 30% glycerol solution (20 mM HEPES-KOH pH7.9, 150 mM KCl, 1.5 mMMgCl2, 0.2 mM EDTA and 30%Glycerol) was over-
laid with 6mL of 10%glycerol solution (20mMHEPES-KOHpH7.9, 150mMKCl, 1.5mMMgCl2, 0.2mMEDTA and 10%Glycerol). To
make sequential glycerol layers, the tube was laid on the bench for 3 hours at room temperature and put the tube vertical for 1 hour in
cold room. Approximately 1 mL of soluble chromatin fraction prepared as previously described was gently overlaid onto sequential
glycerol solution and immediately centrifuge at 30,000 rpm for 1820 hours at 4C. After the ultracentrifuge, 22 fractions (500 mL
each) were separated for the top of the tube. Fractions #1(top)-6, #7-14, #15-22 were pooled for 3 rough fractions called light, middle
and heavy, respectively. The rest (1 mL) of sample called fraction #23 at bottom was not used for further Pol II IP step since aggre-
gates were observed. After Pol II IP, standard mNET-seq protocol was followed as previously described (Nojima et al., 2016).
QUANTIFICATION AND STATISTICAL ANALYSIS
mNET-seq and RNA-seq data processing
Data pre-processing was performed as previously described (Nojima et al., 2016). Read Coverage, gene elements comparison and
manipulation were performed using bedtools (v2.25.0) (Quinlan and Hall, 2010). Meta-profiles, splice junction average profiles and
individual profiles were generated as described (Nojima et al., 2015).Molecular Cell 72, 369–379.e1–e4, October 18, 2018 e2
Nucleoplasmic RNA-seq data analysis
Strand-specific nucleoplasmic RNA-seq data was analyzed with Tophat(v2.0.13)/Cufflinks(v2.2.0) (Trapnell et al., 2010) using
Ensembl Homo sapiens GRCh37.74 release as template for quantification. zFPKM values for each transcript were converted to
log2 and their distribution plotted. The threshold value chosen to identify expressed genes was the local minimum between the
peak of high-expressed genes and low-expressed genes as described in (Hart et al., 2013).
Annotation
Annotations for TSS, introns, exons and alternative splicing events were retrieved from Ensembl for hg19 andmm10 genome version
(Karolchik et al., 2004; Rosenbloom et al., 2015). Constitutive events were retrieved fromEnsembl andU12-type spliceosomal introns
retrieved from U12DB through a liftOver tool to bring all genetical information to the same reference build (Alioto, 2007).
mNET-Mass Spectrometry data analysis
Spectral counts for each specific IP along with the respective mock control were used for analysis. Missing values were imputed, and
data were normalized by median subtraction as described (Harlen et al., 2016). Enriched proteins were defined using a false discov-
ery rate (FDR) of 0.05.
snRNA read counts
A list of all ENSEMBL genes was filtered to select all genes containing U1, U2, U3, U4, U5, U6 or U7 in the respective gene symbol,
grouping the genes by each snRNA category. The obtained list was then manually curated to remove incorrectly classified genes.
Afterward, the number of nucleoplasm-fraction RNA reads was counted for non-overlapping snRNA genes, and the ones with a
log2(RPM) equal or greater than 1 for this sample were considered expressed, constituting the gene set used in the analysis. For
this final snRNA set, reads were counted and normalized to RPM for every tested sample, adding 5 bases to the annotated coordi-
nates to account for possible annotation uncertainties, and RPM values for genes belonging to the same snRNA category
were added.
mNET-seq peak finding analysis
To identify spikes in the density of 30 ends of nascent transcripts we used an algorithm that finds nucleotides where the read density is
at least three standard deviations above the mean in a local region (Churchman and Weissman, 2011). Only positions with coverage
of 4 or more reads were considered. To identify peaks at the 30 end of exons and introns indicative of splicing intermediates, the
number of reads at these positions was compared to the mean read density across the corresponding exon or intron. To identify
peaks corresponding to Pol II pause positions along exons and introns avoiding contamination by 50 ss splicing intermediates, we
removed reads aligning to the last 3 nucleotides of exons and the first 3 nucleotides of introns. The number of reads at each
nucleotide position along the exon was then compared to the mean read density across the entire exon. Peaks were identified in
the annotated exons and introns of expressed genes. Exons that intersected other isoform exons were discarded and the same
principle was applied for introns.
Percent-spliced-in (PSI) calculation
To obtain ameasure of splicing completeness for any given exon, the percent-spliced-in (PSI)metric (Barbosa-Morais et al., 2012) was
applied tonucleoplasmicRNA-seqdatasets.Whencalculating this index, exons that havealternative 30 or 50 splice siteswereexcluded
from the analysis, aswell as exonsoverlappingother exonson the same strand andexonswith less than 100bp, orwhich thepreceding
intron had less than 100bp. Finally, only junctions that had a total of at least 5 reads in both regions were included in the analysis.
Identification of spliced events
Detection of spliced events was based on spliced reads obtained in mNET-seq/S5P experiments. Reads that aligned uniquely and
with no mismatch across two exons were classified as spliced reads. To reduce the possibility of fortuitous alignments, only reads
that map to more than 8 nucleotides across any junction were considered. A splicing event was considered if the 30 SS was covered
by 3 or more reads.
Splicing associated with 50 ss peak
Merely spliced or unsplicedmNET-seq/S5P reads that specifically align to the last nucleotide of exons were taken into consideration.






‘‘SR’’ stands for spliced reads and ‘‘UR’’ unspliced reads. Significance of the differences between the mean and distribution of the
percentage of splicing for skipping and constitutive exons was calculated through a Wilcoxon signed-rank test and Kolmogorov-
Smirnov tests, respectively.e3 Molecular Cell 72, 369–379.e1–e4, October 18, 2018
mNET-seq read density analysis





‘‘TR’’ stands for the total number of reads along the exon and ‘‘EL’’ to the exon length. The last 3 nucleotides of exons and the
first 3 nucleotides of introns are removed because of the high read densities associated with 50 ss splicing intermediates. For
each group of exons considered, exons without reads were not considered and the signal originating from spliced reads was
removed.
DATA AND SOFTWARE AVAILABILITY
All the sequencing data and mass spectrometry data used in this work is submitted at GEO: GSE106881 and ProteomeXchange:
PXD008197. Original images of western blot are available at Mendeley data https://doi.org/10.17632/cy8mj7sxp9.1. Software’s
used in this work are all publicly available, with the links to them in the above tables.Molecular Cell 72, 369–379.e1–e4, October 18, 2018 e4
